Cite
Assessment of the effectiveness of Budesonide MMX® for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study.
MLA
Jesionowski, Maciej, et al. “Assessment of the Effectiveness of Budesonide MMX® for Active, Mild-to-Moderate Ulcerative Colitis in the Polish Sub-Group of the CORE Practice Prospective Multi-Centre Observational Study.” Gastroenterology Review / Przegląd Gastroenterologiczny, vol. 18, no. 2, Apr. 2023, pp. 154–60. EBSCOhost, https://doi.org/10.5114/pg.2023.129413.
APA
Jesionowski, M., Rydzewska, G., Danese, S., & Paridaens, K. (2023). Assessment of the effectiveness of Budesonide MMX® for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study. Gastroenterology Review / Przegląd Gastroenterologiczny, 18(2), 154–160. https://doi.org/10.5114/pg.2023.129413
Chicago
Jesionowski, Maciej, Grażyna Rydzewska, Silvio Danese, and Kristine Paridaens. 2023. “Assessment of the Effectiveness of Budesonide MMX® for Active, Mild-to-Moderate Ulcerative Colitis in the Polish Sub-Group of the CORE Practice Prospective Multi-Centre Observational Study.” Gastroenterology Review / Przegląd Gastroenterologiczny 18 (2): 154–60. doi:10.5114/pg.2023.129413.